Fair Value Calculator Fair Value Calculator
EN DE

TRIVENIENT (TRIVENIENT) Fair Value & Analysis

IN · Market cap ₹57.8M

T TRIVENIENT TRIVENIENT · BSE
Price₹1.01
Fair Value₹0.4800
Upside-52.5%
Quality51/100
Watch TRIVENIENT for free — get notified when fair value or trend changes. Watch for free
Evidence: Low Range ₹0.3600 – ₹0.6000

Fair value as of: Jul 6, 2026

From 6 valuation models · updated today

Share price −8.2% over the past month.

Price vs Fair Value (12 months)

₹1.74 ₹1.00 Fair Value ₹0.4800 Jul 2025 Jul 2026

12‑month range ₹1.00 – ₹1.74 · fair‑value band ₹0.3600 – ₹0.6000 · the ₹1.01 price screens above the ₹0.4800 fair value. As of Jul 6, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

TRIVENIENT (TRIVENIENT) currently trades at ₹1.01, while our model-based Fair Value estimate is ₹0.4800 — implying the stock looks roughly 52.5% overvalued today. We read business quality at 51/100 (solid quality). Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

Over the trailing twelve months, TRIVENIENT generated revenue of ₹4.6M at a net margin of 30.1%. Revenue declined 78.7% year over year. It earns a return on equity of 1.3%. The stock trades on a trailing P/E of 50.5. Fundamentals as of Jul 6, 2026

Our scenario range runs from ₹0.3600 (bear case) to ₹0.6000 (bull case); at ₹1.01, the current price sits above that range. The share trades about 42% below its 52-week high and 2% above its 52-week low, currently below its 200-day average.

Key figures & financial health

Revenue (TTM) ₹4.6M
Revenue growth (YoY) -78.7%
Net margin 30.1%
Return on equity 1.3%
Free cash flow −₹6.9M FY2026
P/E ratio 50.5
More key figures
Operating margin -44.9%
EPS (TTM) ₹0.0200
EPS growth (YoY) -83.8%

Figures from reported company fundamentals (EODHD) · as of Jul 6, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

TRIVENIENT reported revenue of ₹0 in FY2026 versus ₹105M in FY2022. Reported net income was ₹1.4M in FY2026, compounding −39.0%/yr from FY2022.

Revenue
FY22 ₹105M
FY23 ₹85.7M
FY24 ₹0
FY25 ₹30.4M
FY26 ₹0
Net income −39.0%/yr
FY22 ₹9.9M
FY23 ₹3.2M
FY24 ₹1.5M
FY25 ₹1.9M
FY26 ₹1.4M

Is TRIVENIENT fairly valued? → Check now

🧮 Run the numbers yourself — free valuation calculators
📤 Share or link this analysis
🔗 Embed on your site (free fair-value badge)

Paste this into your site or blog — it shows the current fair value and links back here (free, and welcome):

Cite: Fair Value Calculator (2026). "TRIVENIENT Fair Value". https://www.fairvalue-calculator.com/stock/TRIVENIENT

Explore undervalued stocks

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is TRIVENIENT (TRIVENIENT) undervalued?
As of Jul 6, 2026, our model estimates a fair value of ₹0.4800 versus a price of ₹1.01 — about −52% (overvalued). Model-based estimate, not financial advice.
What is the fair value of TRIVENIENT?
Our model-based fair value for TRIVENIENT is ₹0.4800 (as of Jul 6, 2026), built from audited fundamentals. The current price is ₹1.01.
What is the quality score of TRIVENIENT?
TRIVENIENT has a Quality Score of 51/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of TRIVENIENT (TRIVENIENT)?
TRIVENIENT reported trailing-twelve-month revenue of about ₹4.6M (latest available figure, as of Jul 6, 2026).
What is the net profit margin of TRIVENIENT?
The net profit margin of TRIVENIENT is about 30.1%, meaning it keeps roughly 30.1% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.